Pulmonary fibrosis in critically ill patients with novel coronavirus pneumonia during the convalescent stage and a proposal for early intervention.

Zou, Hai; Li, Sheng-Qing

Zou, Hai; Li, Sheng-Qing.

Zou H; Department of Pulmonary and Critical Care Medicine, Huashan Hospital, Fudan University, Shanghai, 200040, China. haire1993@163.com.
Li SQ; Department of Pulmonary and Critical Care Medicine, Huashan Hospital, Fudan University, Shanghai, 200040, China. shengqingli9655@163.com.

Acta Pharmacol Sin ; 42(8): 1376-1378, 2021 08.

Article in English | MEDLINE | ID: covidwho-926074

Subject(s)

COVID-19 Drug Treatment; Convalescence; Glucocorticoids/therapeutic use; Pulmonary Fibrosis/drug therapy; Acetylcysteine/therapeutic use; COVID-19/complications; Early Medical Intervention; Humans; Indoles/therapeutic use; Pulmonary Fibrosis/etiology; Pyridones/therapeutic use; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pulmonary Fibrosis / Convalescence / COVID-19 Drug Treatment / Glucocorticoids Type of study: Experimental Studies Topics: Long Covid Limits: Humans Language: English Journal: Acta Pharmacol Sin Journal subject: Pharmacology Year: 2021 Document Type: Article Affiliation country: S41401-020-00566-4

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google